Nayden Denis 4
4 · Accretive Health, Inc. · Filed Jan 5, 2012
Insider Transaction Report
Form 4
Nayden Denis
Director
Transactions
- Award
Director Stock Option (right to buy)
2012-01-03$11.36/sh+1,320$14,995→ 1,320 totalExercise: $23.27From: 2012-01-03Exp: 2022-01-03→ Common Stock (1,320 underlying)
Footnotes (1)
- [F1]This option was issued to the reporting person pursuant to the Accretive Health director compensation plan in lieu of retainer fees of $15,000.